Why Oriola stock moves
Oriola rose sharply, while the market fell slightly.
Written after the close on ·
Why today
16,437 news analyzed todayOriola rose sharply, while the market fell slightly.
No company news explains the move.
Over the last five trading days Oriola rose slightly, in line with the market.
The most likely reason is general investor sentiment, not a specific event.
Oriola's next earnings report is due on Tuesday 23 February 2027.
Today's move of +1.42% was 2.1 times a normal day's 0.7%. OMX Helsinki 25 moved −0.52% on the same day.
Oriola +1.42%OMX Helsinki 25 −0.52%Against the market
What analysts expect, and how often they have been right
Analysts’ estimates for Oriola.
Oriola earned more than expected in 4 out of 8 reports.
Not in the chart because no estimate and result are available: 2 of the 10 reports in this period, the latest on April 29, 2026.
For comparison, about 46% of reports from Nordic companies beat the estimate in the last three years.
The share moved in the same direction as the earnings surprise in 6 out of 8 reports with a measured move, against about 63% of reports from Nordic companies.
Ratings
Price targets
Latest price 0.79 EUR
Earnings against expectations, and the share’s reaction
Expected EPSAbove estimateBelow estimateAs expectedEUR
Next reported quarter: expected earnings per share of 0.04 EUR (February 23). For the current fiscal year, expected earnings per share changed from 0.07 EUR three months ago to 0.07 EUR now. 2026 estimate: 0.07 EUR. 2027 estimate: 0.10 EUR.
Has the share price followed the business?
Price and earnings moved in the same direction: 1 out of 3 years. Across Nordic companies, that happens in about 60% of years. In 2025, the price changed +29% and earnings per share went from -0.11 EUR to -0.15 EUR.
Revenue, profit and market cap
RevenueProfitMarket capHatched bars: analysts’ estimates.bn EUR
Assets, liabilities and market cap
AssetsLiabilitiesMarket capbn EUR
Price and earnings moved in the same direction: 1 out of 3 years.Market cap (Now): 145 m EURRevenue 2025: 1.9 bn EUR
What the key figures say about Oriola
The figures connect what Oriola earns with what investors pay.
The line shows the share price in the same year, on its own scale. Hatched bars: analysts’ estimates.
Profit divided by the number of shares. Each share represents this much of the earnings.
2022–2025: -0.15 EUR–-0.01 EUR. Peers: BICO Group -18.91 SEK, Carasent 0.59 SEK, Pyxis Oncology -$1.27. 2026 estimate: 0.07 EUR (0.07 EUR–0.08 EUR). 2027 estimate: 0.10 EUR (0.08 EUR–0.12 EUR).
What the company sold during the year.
2022–2025: 1.5 bn EUR–1.9 bn EUR. Peers: BICO Group 1.5 bn SEK, Carasent 390 m SEK, Pyxis Oncology $11.0M. 2026 estimate: 217 m EUR (216 m EUR–217 m EUR). 2027 estimate: 222 m EUR (215 m EUR–227 m EUR).
The percentage of revenue left after the costs of running the business.
2022–2025: −0.4%–0.8%. Peers: BICO Group −16.4%, Carasent 4.1%, Pyxis Oncology −834.4%.
Profit as a percentage of shareholders’ money in the company.
2022–2025: −27.0%–−1.1%. Peers: BICO Group −66.3%, Carasent 4.8%, Pyxis Oncology −179.1%.
What investors pay for each unit the company sells.
2022–2025: 0.10–0.21. Peers: BICO Group 1.14, Carasent 4.43, Pyxis Oncology 17.99. 2026 estimate: 0.67. 2027 estimate: 0.65.
Money paid to shareholders per share, summed by calendar year.
2017–2025: 0.03 EUR–0.14 EUR.
The ordinary yearly dividend as a percentage of the share price.
2022–2025: 2.3%–7.9%. Peers: BICO Group 0.0%, Carasent 0.0%, Pyxis Oncology 0.0%.
Net debt divided by operating earnings before depreciation and amortisation.
2022–2025: -0.90–-0.69. Peers: Carasent -0.71.
More key figures
Market cap divided by shareholders’ equity, what remains after liabilities.
2022–2025: 1.15–2.11. Peers: BICO Group 1.10, Carasent 2.12, Pyxis Oncology 1.95.
Cash left after investments, divided by the number of shares.
2022–2025: 0.03 EUR–0.38 EUR. Peers: BICO Group 0.61 SEK, Carasent 0.87 SEK, Pyxis Oncology -$0.57.
The percentage of assets financed by shareholders’ equity.
2022–2025: 10.7%–23.5%.
The dividend explained
A dividend is money paid to shareholders. Oriola paid 0.03 EUR per share in the twelve months through November 6, 2026.
On the ex-dividend day, March 26, 2026, Oriola traded without the right to the 0.03 EUR dividend. The price went from 0.98 EUR to 0.96 EUR; including the dividend, the day's change was +1.2%. Entitlement passes from the company to shareholders on the ex-day; payment comes later.
2017: 0.14 EUR2018: 0.09 EUR2019: 0.09 EUR2020: 0.09 EUR2021: 0.03 EUR2022: 0.04 EUR2023: 0.06 EUR2024: 0.07 EUR2025: 0.07 EUR2026 so far: 0.03 EUR
What to watch next, and why
The earnings report shows how Oriola's revenue and profit have changed.
- Earnings report
The earnings report shows how Oriola's revenue and profit have changed.
Add to calendar
Earnings report
Next report: · Add to calendar · Google Calendar
On its last 15 report days Oriola usually moved about 2.0%. On a normal day it moves 0.7%.
+5.88% Why? +0.54% −1.48% −6.23%
10,000 EUR in Oriola bought on November 7, 2016 is worth 2,750 EUR today, with dividends reinvested.
The same amount in OMX Helsinki with dividends would have become 24,400 EUR.
What would 10,000 EUR in Oriola be worth today? →
What would 10,000 EUR in Oriola be worth today?
2,750 EUR
with dividends reinvested, bought on November 7, 2016. The same amount in OMX Helsinki with dividends would have become 24,400 EUR.
At worst it was worth 2,590 EUR (October 14, 2026).
The five biggest days of the journey
· +10.3% · the whole market rose 1.6% the same day
· +10.0% · the whole market was unchanged the same day
· −10.0% · the whole market fell 0.3% the same day
· −9.9% · the whole market fell 10.1% the same day
· +9.5% · the whole market fell 0.3% the same day · report day
Earlier days
+0.64% market +0.50% Oriola rose slightly over the week, moving in line with the OMX Helsinki 25 index, which also rose slightly. Read →
Oriola rose slightly over the week, moving in line with the OMX Helsinki 25 index, which also rose slightly.
The shares rose sharply in the last session, moving against a slightly weaker market that day.
Company news was thin: the main event was the late-October interim report, published before this week, which showed sales up 5.1% in the quarter, adjusted EBITDA flat and guidance for higher adjusted EBITDA in 2026.
The next earnings report is due on 23 February 2027.
−1.40% market −0.56% Oriola fell sharply without company news. Read →
Oriola fell sharply without company news.
Over the last five trading days it fell clearly while the Helsinki market was roughly flat.
The shares sit well below their January high and above their October low.
Its Q3 results were about in line with expectations, and the company kept its 2026 adjusted EBITDA outlook, so the drop does not clearly trace to those figures.
−1.52% market −1.16% Oriola fell, moving in line with a clearly falling market. Read →
Oriola fell, moving in line with a clearly falling market.
Company news from the day before, the Q3 report, did not explain the drop.
The report showed sales up 5.1% and a small profit, so the fall likely reflects general market selling.
Over the last five trading days Oriola rose sharply while the market was roughly flat, a big move for this stock.
The latest close sits well below the past year's high from mid January and above the low from mid October.
+3.59% market +0.22% Oriola rose sharply over the week while the Helsinki market stayed roughly flat. Read →
Oriola rose sharply over the week while the Helsinki market stayed roughly flat.
The rise is a big move for the company and rare over the past year.
The main driver was its interim report on 29 October, which showed sales growth of about 5% in the quarter.
Management held its guidance, the company's outlook for the year, and expects adjusted EBITDA, its core operating profit before some items, to rise in 2026.
+5.88% market +0.35% Oriola rose, while OMX Helsinki 25 rose only slightly. Read →
Oriola rose, while OMX Helsinki 25 rose only slightly.
Oriola's interim report, published that morning, showed Q3 net sales up 5.1%, with guidance held.
Its shares moved far more than a normal day, and trading was well above usual.
Over the last five trading days the stock rose sharply, also well ahead of the market.
+1.48% market −0.14% Oriola rose sharply. Read →
Oriola rose sharply.
No company news explains the move.
Over the last five trading days the shares were roughly unchanged.
Trading was well below its usual level, so the move may reflect few buyers and sellers.
Oriola's latest close is near its lowest level of the past year, but well below its highest.
−1.46% market +1.83% Oriola fell, against a market that rose sharply. Read →
Oriola fell, against a market that rose sharply.
No company news explains the move.
Over the last five trading days the stock fell slightly while the OMX Helsinki 25 was roughly flat.
The latest close sits near its lowest level of the past year.
The next earnings report is due Thursday 29 October 2026, which investors may watch closely.
+0.80% market −3.27% Oriola, the Finnish pharmacy and healthcare company listed on Nasdaq Helsinki, rose slightly over the last five trading days, moving against a falling market. Read →
Oriola, the Finnish pharmacy and healthcare company listed on Nasdaq Helsinki, rose slightly over the last five trading days, moving against a falling market.
Over the same days the OMX Helsinki 25 index fell clearly, so Oriola held up better than the broad market.
The move was ordinary in size for the stock.
The company's own news was thin: mostly notices that it will publish its January-September interim report on Thursday 29 October.
−1.95% market −1.41% Oriola fell sharply; no company news explains it. Read →
Oriola fell sharply; no company news explains it.
In the last trading day, its shares fell sharply.
The OMX Helsinki 25 index also fell clearly, so Oriola moved in line with the market.
+1.99% market +0.61% Oriola rose sharply, moving more than the market. Read →
Oriola rose sharply, moving more than the market.
No company news explains the move, and trading was lighter than usual.
Over the last five trading days Oriola rose sharply while OMX Helsinki 25 fell clearly, so the stock moved against the market.
That is a big move for Oriola, about three times a normal five-day stretch.
Learn more · Why do stocks go up and down?